The role of chromogranin A in the management of patients with phaeochromocytoma

Clinical Endocrinology

Volumn 65, Issue 3, 2006, Pages 287-293

  Grossrubatscher, Erika ^a   Dalino, Paolo ^a   Vignati, Federico ^a   Gambacorta, Marcello ^a   Pugliese, Raffaele ^a   Boniardi, Marco ^a   Rossetti, Ornella ^a   Marocchi, Alessandro ^a   Bertuzzi, Michaela ^a   Loli, Paola ^a,b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CHROMOGRANIN A; METADRENALIN; NORMETADRENALIN;

ADULT; AGED; ARTICLE; CATECHOLAMINE URINE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; DRUG SPECIFICITY; FEMALE; HUMAN; MALE; NEUROECTODERM TUMOR; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; AREA UNDER CURVE; CASE-CONTROL STUDIES; CATECHOLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMOGRANIN A; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; MALE; METANEPHRINE; MIDDLE AGED; NORMETANEPHRINE; PHEOCHROMOCYTOMA; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33747337212     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02591.x     Document Type: Article

References (22)

1. Kim, T., Tao-Cheng, J.H., Eiden, L.E. & Loh, Y.P. (2001) Chromogranin A, an 'on/off ' switch controlling dense-core secretory biogenesis. Cell, 106, 499-509.
2. Taupenot, L., Harper, K.L. & O'Connor, D.T. (2003) The chromogranin-secretogranin family. New England Journal of Medicine, 348, 1134-1149.
3. Wiedenmann, B. & Huttner, W.B. (1989) Synaptophysin and chromogranins/secretogranins - widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis. Virchows Archive B: Cell Pathology Including Molecular Pathology, 58, 95-121.
4. Hsiao, R.J., Parmer, R.J., Takiyyuddin, M.A. & O'Connor, D.T. (1991) Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma. Medicine, 70, 33-45.
5. Canale, M.P. & Bravo, E.L. (1994) Diagnostic specificity of serum chromogranin-A for pheochromocytoma in patients with renal dysfunction. Journal of Clinical Endocrinology and Metabolism, 78, 1139-1144.
6. Kimura, N., Miura, W., Noshiro, T., Mizunashi, K., Hanew, K., Shimizu, K., Watanabe, T., Shibukawa, S., Sohn, H.E., Abe, K., Miura, Y. & Nagura, H. (1997) Plasma chromogranin A in pheochromocytoma, primary hyperparathyroidism and pituitary adenoma in comparison with catecholamine, parathyroid hormone and pituitary hormones. Endocrine Journal, 44, 319-327.
7. Nobels, F.R., Kwekkeboom, D.J., Coopmans, W., Schoenmakers, C.H., Lindemans, J., De Herder, W.W., Krenning, E.P., Bouillon, R. & Lamberts, S.W. (1997) Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. Journal of Clinical Endocrinology and Metabolism, 82, 2622-2628.
8. Stridsberg, M. & Husebye, E.S. (1997) Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma. European Journal of Endocrinology, 136, 67-73.
9. Baudin, E., Gigliotti, A., Ducreux, M., Ropers, J., Comoy, E., Sabourin, J.C., Bidart, J.M., Cailleux, A.F., Bonacci, R., Ruffie, P. & Schlumberger, M. (1998) Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours. British Journal of Cancer, 78, 1102-1107.
10. Bernini, G.P., Moretti, A., Ferdeghini, M., Ricci, S., Letizia, C., D'Erasmo, E., Argenio, G.F. & Salvetti, A. (2001) A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours. British Journal of Cancer, 84, 636-642.
11. d'Herbomez, M., Gouze, V., Huglo, D., Nocaudie, M., Pattou, F., Proye, C., Wemeau, J.L. & Marchandise, X. (2001) Chromogranin A assay and 131 I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma. Journal of Nuclear Medicine, 42, 993-997.
12. Guignat, L., Bidart, J.M., Nocera, M., Comoy, E., Schlumberger, M. & Baudin, E. (2001) Chromogranin A and the alpha-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma. British Journal of Cancer, 84, 808-812.
13. Giovanella, L. & Ceriani, L. (2002) Serum chromogranin-alpha immunoradiometric assay in the diagnosis of pheochromocytoma. International Journal of Biology Markers, 17, 130-134.
14. Rao, F., Keiser, H.R. & O'Connor, D.T. (2002) Malignant and benign pheochromocytoma: chromaffin granule transmitters and the response to medical and surgical treatment. Annals of the New York Academy of Sciences, 97, 530-532.
15. van der Harst, E., de Herder, W.W., de Krijger, R.R., Bruining, H.A., Bonjer, H.J., Lamberts, S.W., van den Meiracker, A.H., Stijnen, T.H. & Boomsma, F. (2002) The value of plasma markers for the clinical behaviour of phaeochromocytomas. European Journal of Endocrinology, 147, 85-94.
16. Hanley, J.A. & McNeil, B.J. (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology, 148, 839-843.
17. Lenders, J.W., Pacak, K., Walther, M.M., Linehan, W.M., Mannelli, M., Friberg, P., Keiser, H.R., Goldstein, D.S. & Eisenhofer, G. (2002) Biochemical diagnosis of pheochromocytoma: which test is best? Journal of the American Medical Association, 287, 1427-1434.
18. Sawka, A.M., Jaeschke, R., Singh, R.J. & Young, W.F. Jr (2003) A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. Journal of Clinical Endocrinology and Metabolism, 88, 553-558.
19. O'Connor, D.T. & Deftos, L.J. (1986) Secretion of chromogranin A by peptide-producing endocrine neoplasms. New England Journal of Medicine, 314, 1145-1151.
20. Goldstein, D.S., Eisenhofer, G., Flynn, J.A., Wand, G. & Pacak, K. (2004) Diagnosis and localization of pheochromocytoma. Hypertension, 43, 907-910.
21. Kairisto, V., Koskinen, P., Mattila, K., Puikkonen, J., Virtanen, A., Kantola, I. & Irjala, K. (1992) Reference intervals for 24-h urinary normetanephrine, metanephrine, and 3-methoxy-4-hydroxymandelic acid in hypertensive patients. Clinical Chemistry, 38, 416-420.
22. Bravo, E.L. & Tagle, R. (2003) Pheochromocytoma: state of the art and future prospects. Endocrine Reviews, 24, 539-553.